The DayOne Accelerator is a strong fit for this pre-seed AI/biotech startup targeting pharma R&D challenges. The venture's validated proof-of-concept and focus on drug resistance prediction align well with the accelerator's mission, though the programme does not specify funding amount or equity terms.